Dr. Leen Kawas: Addressing the Disconnect in Clinical Trials

Clinical trials are a huge part of any medical development.

They are used to “test out” drugs and other therapies to improve patient care.

These studies point out potential side effects, help gauge how well the treatment will work, and provide vital information to increase the quality of care for patients.

Also read: Leen Kawas, Athira Pharma Inc: Profile and Biography – Bloomberg Markets

However, clinical trials often suffer from significant disconnects between key stakeholders, both before and during the trial.

Dr. Leen Kawas, a pharmacist and entrepreneur, has developed a new and improved way to emphasize communication among these vital parties, making the entire clinical trial much more successful in gathering valuable data.

Early Feedback is the Key to Effective Clinical Trials

The current disconnect among stakeholders results in a poor patient experience throughout the trial.

It also produces questionable data that may not be as useful to researchers and developers.

To address this issue, Dr. Leen Kawas states that early feedback is critically important: “It is essential to get patients’ input early and frequently during study protocol development.”

Dr. Kawas’ method is in stark contrast to current operations, which often wait until late in the study to gather feedback from patients and others involved in the study.

Having input during the protocol stage sets the entire trial up for success before starting.

It affects the following areas:

  • Operations. Getting input at the beginning of the study helps create effective processes, decreasing the likelihood that the protocols will have to be adjusted during the study.
  • Conduct. Feedback helps adjust recruitment efforts as well as general oversight and reporting.
  • Patient experience. Without talking to the patients about their experience, it is nearly impossible to get good information on this subject and make for the best experience possible.
  • Results. Asking the right questions frequently generally produces better, more reliable data.

In addition to feedback, crafting the right multidisciplinary team to conduct the study and encouraging that team to work together is vital.

Continued collaboration even after the study starts will also make the trial more useful across the board.

Connect to Leen Kawas on Linkedin.com

Learn more about Kawas: https://en.everybodywiki.com/Leen_Kawas